Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum

Journal of Ethnopharmacology

Volumn 68, Issue 1-3, 1999, Pages 129-136

  Eo, Seong Kug ^a   Kim, Young So ^a   Lee, Chong Kil ^a   Han, Seong Sun ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Antiviral activity; Basidiomycetes; Ganoderma lucidum; Herpes simplex viruses; Vesicular stomatitis viruses

Indexed keywords

GANODERMA LUCIDUM EXTRACT; METHANOL; WATER;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BASIDIOMYCETES; CYTOPATHOGENIC EFFECT; DRUG ISOLATION; DRUG SELECTIVITY; DRUG SOLUBILITY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; NONHUMAN; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 1, HUMAN; INFLUENZA A VIRUS; PLAQUE ASSAY; REISHI; SENSITIVITY AND SPECIFICITY; SOLUBILITY; VERO CELLS; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0032692479     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(99)00067-7     Document Type: Article

References (29)

1. Bacon T.H., Howard B.A., Spender L.C., Boyd M.R. Activity of penciclovir in antiviral assays against herpes simplex virus. J. Antimicrob. Chemother. 37:1996;303-313.
2. Hikino H., Konno C., Mirin Y., Hayashi T. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med. 51:1985;339-340.
3. Kim B.K., Chung H.S., Chung K.S., Yang M.S. Studies on the antineoplastic components of Korean basidiomycetes. Korean J. Mycol. 8:1980;107-113.
4. Kim B.K., Cho H.Y., Kim J.S., Kim H.W., Choi E.C. Studies on constituents of higher fungi of Korea(LXVIII). Antitumor components of the cultured mycelia of Ganoderma lucidum. Korean J. Pharmacogn. 24(3):1993;203-212.
5. Kim M.J., Kim H.W., Lee Y.S., Shim M.J., Choi E.C., Kim B.K. Studies on safety of Ganoderma lucidum. Korean J. Mycol. 14(1):1986;49-59.
6. Kim S.H., Kim H.W., Choi E.C., Kim B.K. Immunological studies on Collybia confluens. J. Korean Cancer Assoc. 25:1993;288-298.
7. Kim S.S., Kim Y.S. Korean Mushrooms. 1990;298-299 Yupoong Publishers, Seoul.
8. Kohda H., Tokumoto W., Sakamoto K. et al. The biologically active constituents of Ganoderma lucidum (Fr.)Karst. Histamine release inhibitory triterpenes. Chem. Pharm. Bull. 33(4):1985;1367-1374.
9. Komoda Y., Nakamura H., Ishihara S., Uchida M., Kohda H., Yamasaki K. Structures of new terpenoid constituents of Ganoderma lucidum. Chem. Pharm. Bull. 33:1985;4829-4835.
10. Larder B.A., Darby G., Richman D.D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 243:1989;1731-1734.
11. Lei L.S., Lin Z.B. Effects of Ganoderma lucidum polysaccharides on T cell subpopulations and production of interleukin 2 in mixed lymphocyte response. Yao-Hsueh-Hsueh-Pao. 27:1992;331-335.
12. Mitsuya H., Broder S. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/ lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA. 83:1986;1911-1915.
13. Miyazaki T., Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull. 29:1981;3611-3616.
14. Moore R.D., Hidalgo J., Sugland B.W., Chaisson R.E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. New Engl. J. Med. 324:1991;1412-1416.
15. Nishitoba T., Sato H., Sakamura S. New terpenoids from Ganoderma lucidum and their bitterness. Agric. Biol. Chem. 49:1985;1547-1549.
16. 30 terpenoids from the fungus Ganoderma lucidum (Reishi). Agric. Biol. Chem. 49:1985;1793-1798.
17. Nogami M., Tsuji Y., Kubo M., Takahashi M., Kimura H., Matsuike Y. Studies on Ganoderma lucidum VI. Anti-allergic effect (1). Yakugaku Zasshi. 106:1986;594-599.
18. Park J.H., Kim H.W., Kim Y.C., Choi E.C., Kim B.K. Studies on antihypertensive components of Ganoderma lucidum in Korea. Korean J. Food Hyg. 2:1987;57-65.
19. Richman D.D., Fischl M.A., Grieco M.H. et al. The AZT Collaborative Working Group. The toxicity of azidothymidine(AZT) in the treatment of patients with AIDS and AIDS-related complex. New Engl. J. Med. 317:1987;192-197.
20. Scubiero D.A., Shoemaker R.H., Paull K.D. et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:1988;4827-4833.
21. Shigeta S., Mori S., Baba M. et al. Antiviral activities of ribavirin, 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide, and 6′-(R)-6′-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob. Agents Chemother. 36(2):1992;435-439.
22. Sone Y., Okuda R., Wada N., Kishida E., Misaki A. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric. Biol. Chem. 49:1985;2541-2653.
23. Sugiura M., Ito H. Toxicological studies of Ganoderma lucidum. Tokyo Yakka Daigaku Kenkyu Nenpo. 27:1977;722-733.
24. Toth J.O., Luu B., Ourisson G. Ganoderic acid T and Z: cytotoxic triterpenes from Ganoderma lucidum. Tetrahedron Lett. 24:1983;1081-1084.
25. Witvrouw M., Desmyter J., De Clercq E. Antivir. Chem. Chemother. 5:1994;345-359.
26. Won S.J., Lee S.S., Ke Y.H., Lin M.T. Enhancement of splenic NK cytotoxic activity by extracts of Ganoderma lucidum mycelium in mice. J. Biomed. Lab. Sci. 2:1989;201-213.
27. Woo E.R., Kim H.J., Kwak J.H. et al. Anti-herpetic activity of various medicinal plant extracts. Arch. Pharm. Res. 20(1):1997;58-67.
28. Yarchoan R., Perno C.F., Thomas R.V. et al. Phase I studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet. 1:1988;76-81.
29. Yarchoan R., Mitsuya H., Thomas R.V. et al. In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxynosine. Science. 245:1989;412-415.